Company Overview and News

1
NTDTY vs. SWCH: Which Stock Should Value Investors Buy Now?

2018-09-13 zacks
Investors interested in stocks from the Technology Services sector have probably already heard of Ntt Data Corporation (NTDTY - Free Report) and Switch (SWCH - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
NTDTY 9613 SWCH

 
NTT Data, Gunma University to test self-driving ride services on public roads near Toyosu

2018-09-13 japantimes.co.jp
A multiday test involving three self-driving vehicles on public roads will kick off Friday in Tokyo, the IT firm and school behind the experiment said Thursday.
NTDTY 9613

 
Tokyo stocks turn lower on selling after rally

2018-09-12 japantimes.co.jp
Stocks turned lower on the Tokyo Stock Exchange Wednesday, hurt by selling after the recent market advance.
NTDTY 9613 9984 SFTBF SFTBY

8
Okta, Inc. (OKTA) CEO Todd McKinnon on Q2 2019 Results - Earnings Call Transcript

2018-09-07 seekingalpha
Good day, and welcome to the Okta Second Quarter Fiscal Year 2019 Earnings Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Catherine Buan, VP of Investor Relations. Please go ahead.
NTDTY OKTA 9613 PANW

 
Ntt Data Corp., Ltd. ADR 2019 Q1 - Results - Earnings Call Slides

2018-08-06 seekingalpha
The following slide deck was published by Ntt Data Corp., Ltd. ADR in conjunction with their 2019 Q1 earnings call.
NTDTY 9613

 
Tokyo stocks end slightly lower in directionless trading

2018-08-06 japantimes.co.jp
Stocks closed slightly lower in directionless trading on the Tokyo Stock Exchange on Monday, with vigorous transactions held in check due to concerns over escalating trade tensions between the United States and China.
NTDTY 9613 9984 SFTBF SFTBY

 
Nikkei edges lower in choppy session amid trade tensions, corp earnings

2018-08-06 reuters
TOKYO, Aug 6 (Reuters) - Japan’s Nikkei share average edged lower in choppy trade on Monday as investors remained cautious amid a raft of corporate earnings and this week’s trade talks between Washington and Tokyo.
ISUZF OBYCF NTDTY ISUZY TM TISCF 9613 7203 TYT TISCY 7202 TOYOF

2
Nikkei edges up in choppy trade but gains limited as trade war weighs

2018-08-06 reuters
TOKYO, Aug 6 (Reuters) - Japan’s Nikkei share average edged up in choppy trade on Monday morning but gains were limited as investors remained cautious ahead of corporate earnings and this week’s trade talks between Washington and Tokyo.
ISUZF NTDTY ALPMF TM TYT TOYOF 4503 ALPMY ISUZY 8306 7203 9613 MUFG 7202 MBFJF MTU

2
Nikkei edges up in choppy trade

2018-08-06 thehindubusinessline
Nippon Steel & Sumitomo Metal Corp surged 1.8 per cent, Astellas Pharma added 1.4 per cent, and Mitsubishi UFJ Financial Group dropped 1.5 per cent.
ISUZF NTDTY ALPMF TM TYT TOYOF 4503 ALPMY ISUZY 8306 7203 9613 MUFG 7202 MBFJF MTU

7
(Correction) -- CLIC Technology, Inc. Announces Appointment of New CEO

2018-08-01 globenewswire
MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- CLIC Technology, Inc. (OTC Pink: CLCI) (the “Company”), announced today the appointment of Roman Bond as its Chief Executive Officer. As a fully-reporting SEC company, the Company is also filing an 8-K with the Securities and Exchange Commission on the appointment.
ABT NTDTY 9613 ABT

 
CLIC Technology, Inc. Announces Appointment of New CEO

2018-08-01 globenewswire
MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- CLIC Technology, Inc. (OTC Pink: CLCI) (the “Company”), announced today the appointment of Roman Bond as its Chief Executive Officer. As a fully-reporting SEC company, the Company is also filing an 8-K with the Securities and Exchange Commission on the appointment.
NTDTY 9613

6
NTT Communications and VMware Expand Global Cloud Partnership

2018-06-28 globenewswire
TOKYO and PALO ALTO, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TYO:9432), and VMware, Inc. (NYSE:VMW), today announced an expansion of a decade-long cloud partnership whereby NTT Com will now offer the Enterprise Cloud (ECL) powered by VMware Cloud Foundation service globally.
NTDTY 9613 9437 NTDMF VMW DCM

5
Progress Software Corporation (PRGS) CEO Yogesh Gupta on Q2 2018 Results - Earnings Call Transcript

2018-06-28 seekingalpha
Progress Software Corporation (NASDAQ:PRGS) Q2 2018 Results Earnings Conference Call June 27, 2018 5:00 PM ET
NTDTY 9613 PRGS

8
Silicon Valley-style coding boot camp seeks to reset Japan Inc.

2018-06-20 japantimes.co.jp
Barely six months after inaugurating a tiny software-coding boot camp in a basement in Tokyo, Silicon Valley transplant Kani Munidasa stood before some of Japan’s top business leaders in February with a warning: software was threatening their future.
NTDTY 9613 SNE SNEJF

8
Silicon Valley-style coding boot camp seeks to reset Japan Inc

2018-06-19 reuters
TOKYO (Reuters) - Barely six months after inaugurating a tiny software-coding boot camp in a basement in Tokyo, Silicon Valley transplant Kani Munidasa stood before some of Japan’s top business leaders in February with a warning: software was threatening their future.
NTDTY 9613 SNE SNEJF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...